Drug comparisons
Tolbutamide vs Insulin Icodec
Tolbutamide vs Insulin Icodec: Oral first-gen sulfonylurea stimulating insulin vs once-weekly basal insulin analog (Awiqli) for type 2 diabetes control.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes considering oral sulfonylureas versus once-weekly insulin therapy may compare Tolbutamide and Insulin Icodec.
Bottom line
Both Tolbutamide and Insulin Icodec treat type 2 diabetes but are not interchangeable due to distinct mechanisms and dosing.
All medication comparisons